MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

To control the coronavirus disease 2019 (COVID-19) pandemic and the emergence of different variants of concern (VoCs), novel vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed. In this study, we report the potent immunogenicity and efficacy induced in hamsters b...

Полное описание

Библиографические подробности

Главные авторы:	Robbert Boudewijns, Patricia Pérez, Adrián Lázaro-Frías, Dominique Van Looveren, Thomas Vercruysse, Hendrik Jan Thibaut, Birgit Weynand, Lotte Coelmont, Johan Neyts, David Astorgano, Dolores Montenegro, Eugenia Puentes, Esteban Rodríguez, Kai Dallmeier, Mariano Esteban, Juan García-Arriaza
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2022-03-01
Серии:	Frontiers in Immunology
Предметы:	SARS-CoV-2 COVID-19 MVA vaccine spike hamsters immunogenicity
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.845969/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!